Objective: Evaluate pharmacokinetic/pharmacodynamic (PK/PD) relationships for the delayed- and extended-release (DR/ER) capsule formulation of amantadine in the treatment of levodopa-related dyskinesia in Parkinson disease. ... ...

请注册登录后继续浏览